ACTEMRA Financial Assistance
Support and information are valuable resources in your fight against RA. That's why ACTEMRA has designed patient support programs to help you during your treatment with ACTEMRA.
The ACTEMRA Copay Card Program
Genentech Rheumatology Access Solutions offers the ACTEMRA Copay Card Program to help you with the out-of-pocket costs of your ACTEMRA® (tocilizumab) prescription.
How does it work?
Each eligible patient who enrolls in the program can receive an ACTEMRA Copay Card Program MasterCard in one of the following ways:
- Through your healthcare provider
- By calling 1-888-MY-ACTEMRA (1-888-692-2836)
- Online at www.ACTEMRAcard.com
Once you receive the Copay Card, you can activate it by visiting www.ACTEMRAcard.com or by calling 1-888-MY-ACTEMRA (1-888-692-2836).
MasterCard is a registered trademark of MasterCard International Incorporated.
Copay card covers up to $3500 per 12 month period of
out of pocket costs for ACTEMRA
Who is eligible for the program?
New or current ACTEMRA patients can use the Program if they:
- Are using ACTEMRA to treat their rheumatoid arthritis (RA) or systemic juvenile idiopathic arthritis (SJIA)
- — RA patients must be 18 years of age or older
- — For SJIA patients, a parent or caregiver who is 18 years of age or older must manage the card
- Do not have a health plan paid for by the federal, state or local government. These include Medicare, Medicare Advantage, Medicaid and TRICARE. These might also include some health plans people have from working for the government
- — For questions, call (888) MY-ACTEMRA (888-692-2836)
- Do not live or get ACTEMRA treatments in Massachusetts
- Do not get help from the Genentech® Access to Care Foundation
The ACTEMRA Copay Card Program is not a benefit plan. This Program helps with co-pays for ACTEMRA only. It does not pay for other costs related to your or your child's visit or infusion.
Genentech reserves the right to change or end this program. This may be done in whole or in part, without notice, at any time.
For more information, call 1-888-MY-ACTEMRA (1-888-692-2836)
Or visit www.ACTEMRAcard.com
Genentech Rheumatology Access Solutions
Genentech is committed to helping you get effective treatment, regardless of your ability to pay. If you are worried about paying for ACTEMRA, the next section, Paying for ACTEMRA, provides information on how we may be able to help.
This information does not take the place of talking to your healthcare provider about either your medical condition or your treatment with ACTEMRA. Talk with your healthcare provider if you have any questions about your treatment with ACTEMRA.
What is ACTEMRA?
ACTEMRA is a prescription medicine called an interleukin-6 (IL-6) receptor Inhibitor. ACTEMRA is used to treat adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a Tumor Necrosis Factor (TNF) antagonist has been used and did not work well
IMPORTANT SIDE EFFECT INFORMATION
Some people have serious infections while taking ACTEMRA, including tuberculosis (TB), and infections caused by bacteria, fungi or viruses that can spread throughout the body. Some people have died from these infections.
Other serious side effects of ACTEMRA include tears (perforation) of the stomach and intestines, changes in blood test results (including low neutrophil count, low platelet count, increase in certain liver function tests and increase in blood cholesterol levels), hepatitis B infection becoming an active infection again and nervous system problems.
ACTEMRA affects the immune system and may increase your risk of certain cancers.
Serious allergic reactions, including death, can happen with ACTEMRA. These reactions may happen with any infusion of ACTEMRA, even if they did not occur with an earlier infusion. Patients must tell their doctor if they have had a previous reaction to ACTEMRA. Patients should not take ACTEMRA if they are allergic to it or any of its ingredients.
Common side effects with ACTEMRA in patients with RA include upper respiratory tract infections (common cold, sinus infections), headache and increased blood pressure (hypertension).
Patients must tell their healthcare provider if they plan to become pregnant or are
pregnant. It is not known if ACTEMRA will harm an unborn baby. Genentech has a registry
for pregnant women who take ACTEMRA. Patients who are pregnant or become pregnant while
taking ACTEMRA must contact the registry at 1-877- 311-8972 or
register online
at https://www.otispregnancy.org/
forms/otis_survey-f161
and talk to their healthcare provider.
Patients must call their healthcare provider for medical advice about any side effects. Patients or caregivers may report side effects to the FDA at 1-800-FDA-1088. Patients or caregivers may also report side effects to Genentech at 1-888-835-2555.
Please see full Prescribing Information, including Boxed Warning and Medication Guide, for additional important safety information.
The resources above are provided in Adobe® Reader® format (PDF). To view or print them, you must have Adobe Reader (version 3.0 or higher) installed on your computer. Download the free Adobe Reader here.
